Literature DB >> 10632239

The millennium of mind, brain, and behavior.

S E Hyman1.   

Abstract

Psychiatry enters the new millennium poised to answer many of its central questions. Given the complexity of the human brain and its interactions with our world, these questions are among the most difficult ever addressed by human science. How is the human brain built? How does it change over the life span? What are the precise genetic and environmental risk factors for mental illnesses? What are the pathophysiologic processes that produce the symptoms and disabilities? How do our treatments, including psychotherapy, work? What objective markers can we discover to monitor the progression of the pathogenic processes and the effects of treatment? How will we discover preventive measures and cures that will be effective in diverse populations and settings? Parallel to the pursuit of its public health agenda, psychiatry will grow closer to neuroscience, behavioral science, and neurology. In so doing, those who practice these disciplines will be better positioned to ask meaningful questions about the relationship among mind, brain, and behavior, and to finally overcome the pervasive Cartesianism that continues to incubate stigma and ignorance about mental illness.

Entities:  

Mesh:

Year:  2000        PMID: 10632239     DOI: 10.1001/archpsyc.57.1.88

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  5 in total

Review 1.  International perspectives on engaging the public in neuroethics.

Authors:  Judy Illes; Colin Blakemore; Mats G Hansson; Takao K Hensch; Alan Leshner; Gladys Maestre; Pierre Magistretti; Rémi Quirion; Piergiorgio Strata
Journal:  Nat Rev Neurosci       Date:  2005-12       Impact factor: 34.870

2.  Rethinking theoretical approaches to stigma: a Framework Integrating Normative Influences on Stigma (FINIS).

Authors:  Bernice A Pescosolido; Jack K Martin; Annie Lang; Sigrun Olafsdottir
Journal:  Soc Sci Med       Date:  2008-04-22       Impact factor: 4.634

Review 3.  What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects?

Authors:  V Ozdemir; N H Shear; W Kalow
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 4.  Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking.

Authors:  Lorraine Caron; Katrina Karkazis; Thomas A Raffin; Gary Swan; Barbara A Koenig
Journal:  Nicotine Tob Res       Date:  2005-04       Impact factor: 4.244

5.  Epidemiology and genetics of common mental disorders in the general population: the PEGASUS-Murcia project.

Authors:  Fernando Navarro-Mateu; Mj Tormo; G Vilagut; J Alonso; G Ruíz-Merino; T Escámez; D Salmerón; J Júdez; S Martínez; C Navarro
Journal:  BMJ Open       Date:  2013-12-03       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.